Tirzepatide Dosing Schedule: A Monthly Guide

The Zepbound injection label describes 2.5 mg weekly for four weeks, then 5 mg, with any further increases in 2.5 mg steps after at least four weeks at the current dose. The table uses four-week blocks rather than calendar months: four weekly injections make a block, and a calendar month can contain an extra injection day. It shows a progression, not a promise that every patient advances on exactly these dates.

This table follows the FDA Zepbound prescribing information. The later rows apply only if another increase is prescribed. A patient who stays on 5 mg does not automatically move through 7.5 mg and beyond simply because the next month has arrived.

Tirzepatide affects appetite and digestion. Nausea, vomiting, diarrhea and constipation can occur during treatment, particularly around initiation and dose increases. A low starting dose creates an adjustment period before more medication is introduced. Taking extra medication to accelerate weight loss skips that safety feature and is not a shortcut to a better result.

An early dose can affect appetite without producing a dramatic scale change. Likewise, little nausea does not mean the medicine is inactive. Track how well you can eat, drink and carry out daily activities, along with weight trends. These observations are more useful for a prescribing decision than comparing your first month with somebody else’s most successful month.

NIDDK’s medication overview describes weight-management medication as part of a broader plan that includes eating habits and physical activity. A dose schedule supports that plan; it does not replace it.

Zepbound increases are separated by at least four weeks, not exactly four weeks regardless of symptoms. Its label asks prescribers to consider response and tolerability when selecting maintenance dosage. Tell your Join Luma clinician when symptoms start, how long they last and whether they interfere with meals or hydration.

• Report repeated vomiting, persistent diarrhea or difficulty meeting your fluid needs.
• Describe constipation, reflux or nausea in practical terms: frequency, severity and impact on daily life.
• Ask for a written plan specifying the next dose and when to review it.

Do not increase because you still feel hungry, and do not decrease solely because the scale moved quickly one week. Appetite, gastrointestinal tolerance and weight change are related but not interchangeable measures. A clinician can decide whether to continue, adjust or investigate another cause of symptoms.

For the adult weight-management regimen discussed here, Zepbound maintenance options are 5, 10 or 15 mg once weekly. The maximum labeled dose is 15 mg weekly. The 2.5 mg dose is for initiation, and 7.5 and 12.5 mg are intermediate escalation steps rather than the listed weight-management maintenance doses.

A maintenance decision considers more than the fastest possible weight change. Your clinician reviews benefits, side effects, nutritional intake, relevant health conditions and other medications. Reaching a goal can also change the purpose of treatment from losing more weight to preserving progress. Continuing care is still important even when the weekly dose no longer changes.

Milligrams describe the amount of medication. Milliliters describe the volume of liquid. Syringe units mark a volume on a particular syringe; they are not a universal medication dose. The same number of milligrams can require a different volume when the concentration changes, so a screenshot of someone else’s syringe instructions is not a safe reference.

Use the guide to GLP-1 concentration, mg, mL and units to understand the terms, then ask your clinician or dispensing pharmacy to confirm your actual directions. Never calculate a new injection amount from a brand table alone. Check a new vial against its own label even if the medication name is unchanged.

The FDA-approved brand injection schedules discussed here are reference information, not a prescription for a compounded formulation. Join Luma offers compounded medications, which are not FDA-approved and were not the products studied in brand clinical trials. Their dose, concentration, directions and beyond-use date must come from your own prescription label and clinician. The FDA explains these distinctions.

Keep your injection date, prescribed dose, symptoms and remaining supply in one place. Before a refill, send your Join Luma clinician the information needed to review whether the current step remains appropriate. Request clarification before injecting if the written dose and syringe directions appear inconsistent. Store the medication according to the pharmacy label rather than borrowing a brand pen’s storage allowance.

For a missed injection or a longer interruption, follow your own label and contact the prescribing clinician. Brand products have specific missed-dose instructions, but a gap can also change tolerability. Do not double an injection or resume an old higher dose on your own. The missed-dose guide explains what information to have ready.

Seek urgent care for severe or persistent abdominal pain, repeated vomiting with dehydration, or other severe symptoms. Call 911 for trouble breathing, swelling of the face or throat, or another potentially life-threatening allergic reaction. Routine scheduling questions belong with your clinician, but serious symptoms should not wait for a portal reply. Tell the clinician about pregnancy plans, diabetes medicines and planned procedures before making treatment changes.

Your Join Luma clinician sets your schedule after reviewing your medical history and response. An educational brand chart does not authorize a change to your compounded prescription. If you are transferring care, share the previous prescription, concentration, last injection date and any side effects so the clinician can assess continuity safely.

Join Luma uses the same price every dose: the price does not change when your dose changes. Plans include clinician oversight, medication if prescribed, necessary supplies and shipping, with no membership fees. Commitment length and patient plan category can affect pricing separately from dose; review the current plan options rather than assuming a dose increase changes your bill.

For refill logistics or questions about a message, contact support@joinluma.com or the patient portal. Clinical changes still require the prescribing clinician. Learn more about weekly injection care if you are preparing for treatment rather than adjusting an existing prescription.